foxo4-dri senolytic peptide human trial

foxo4-dri senolytic peptide human trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI: Human Trial Status, Cancer

Name: foxo4-dri senolytic peptide human trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI: Human Trial Status, Cancer
Brand: zahn-charlottenburg.de
SKU: 86566189389
Price: 24.21 USD
Availability: InStock
Rating: 4.1476 (25 reviews)

SKU: 86566189389

4.1

USD24.21 USD74.21

Pay in 4 interest-free payments of $6.05 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

The research identifies a dysfunctional EIF3H/YAP proteolytic axis as a key mediator between cancer-associated adipocytes and drug response

Boakye E, Erhabor J, Obisesan O, Tasdighi E, Mirbolouk M, Osuji N, et al

I dont need the needles, however

QPCR was performed using the Universal Probe Library system (Roche) with the following primer/probe combinations (53), also listed in Table S1: FOXO1 (NM_002015.3): Fwd: tggttttagaaacccaagttcc, Rev: ttggcaccaagttcagttaca